95 related articles for article (PubMed ID: 16380120)
1. The translocation mechanism of P-glycoprotein.
Callaghan R; Ford RC; Kerr ID
FEBS Lett; 2006 Feb; 580(4):1056-63. PubMed ID: 16380120
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state.
Tombline G; Donnelly DJ; Holt JJ; You Y; Ye M; Gannon MK; Nygren CL; Detty MR
Biochemistry; 2006 Jul; 45(26):8034-47. PubMed ID: 16800628
[TBL] [Abstract][Full Text] [Related]
3. The coupling mechanism of P-glycoprotein involves residue L339 in the sixth membrane spanning segment.
Rothnie A; Storm J; McMahon R; Taylor A; Kerr ID; Callaghan R
FEBS Lett; 2005 Jul; 579(18):3984-90. PubMed ID: 16004994
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol interaction with the daunorubicin binding site of P-glycoprotein.
Wang E; Casciano CN; Clement RP; Johnson WW
Biochem Biophys Res Commun; 2000 Oct; 276(3):909-16. PubMed ID: 11027568
[TBL] [Abstract][Full Text] [Related]
5. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
[TBL] [Abstract][Full Text] [Related]
6. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
7. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).
Ambudkar SV; Kim IW; Sauna ZE
Eur J Pharm Sci; 2006 Apr; 27(5):392-400. PubMed ID: 16352426
[TBL] [Abstract][Full Text] [Related]
8. ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2005 Aug; 44(30):10250-8. PubMed ID: 16042402
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
10. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic differences between GSH transport by multidrug resistance protein 1 (MRP1/ABCC1) and GSH modulation of MRP1-mediated transport.
Rothnie A; Conseil G; Lau AY; Deeley RG; Cole SP
Mol Pharmacol; 2008 Dec; 74(6):1630-40. PubMed ID: 18768387
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
[TBL] [Abstract][Full Text] [Related]
13. Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"?
Loo TW; Clarke DM
Biochem Biophys Res Commun; 2005 Apr; 329(2):419-22. PubMed ID: 15737603
[TBL] [Abstract][Full Text] [Related]
14. Bivalent probes of the human multidrug transporter P-glycoprotein.
Pires MM; Hrycyna CA; Chmielewski J
Biochemistry; 2006 Sep; 45(38):11695-702. PubMed ID: 16981729
[TBL] [Abstract][Full Text] [Related]
15. Structure of the multidrug resistance P-glycoprotein.
Higgins CF; Callaghan R; Linton KJ; Rosenberg MF; Ford RC
Semin Cancer Biol; 1997 Jun; 8(3):135-42. PubMed ID: 9441943
[TBL] [Abstract][Full Text] [Related]
16. Residue G346 in transmembrane segment six is involved in inter-domain communication in P-glycoprotein.
Storm J; O'Mara ML; Crowley EH; Peall J; Tieleman DP; Kerr ID; Callaghan R
Biochemistry; 2007 Sep; 46(35):9899-910. PubMed ID: 17696319
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein related drug interactions: clinical importance and a consideration of disease states.
Lee CA; Cook JA; Reyner EL; Smith DA
Expert Opin Drug Metab Toxicol; 2010 May; 6(5):603-19. PubMed ID: 20397967
[TBL] [Abstract][Full Text] [Related]
18. Multidrug transporters from bacteria to man: similarities in structure and function.
van Veen HW; Konings WN
Semin Cancer Biol; 1997 Jun; 8(3):183-91. PubMed ID: 9441947
[TBL] [Abstract][Full Text] [Related]
19. Providing a molecular mechanism for P-glycoprotein; why would I bother?
Callaghan R
Biochem Soc Trans; 2015 Oct; 43(5):995-1002. PubMed ID: 26517914
[TBL] [Abstract][Full Text] [Related]
20. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.
Fox E; Bates SE
Expert Rev Anticancer Ther; 2007 Apr; 7(4):447-59. PubMed ID: 17428165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
